Reflux Esophagitis Clinical Trial
Official title:
Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation (VISTAEXE)
The purpose of this study is to exploratorily evaluate the effect of vonoprazan 20 mg on sleep disturbance of patients with reflux esophagitis, who have heartburn and/or regurgitation and ≥ 6.0 in the Pittsburgh Sleep Quality Index (PSQI) global score despite the maintenance treatment with PPI other than vonoprazan.
The purpose of this study is to evaluate the effect of vonoprazan on sleep disturbance in the
participants under maintenance treatment for reflux esophagitis with proton pump inhibitor
(PPI) other than vonoprazan after initial treatment.
Participants who have been diagnosed as reflux esophagitis based on Los Angeles (LA)
Classification Grades A to D, undergoing maintenance treatment with PPI other than vonoprazan
after initial treatment, and with Pittsburgh Sleep Quality Index (PSQI) global score >= 6.0
at enrolment (VISIT 1) will be eligible for study entry and will be administered vonoprazan
20 mg once daily for 8 weeks.
Planned number of participants is 25. The study period is 9 weeks. The number of visits is
6visits.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06170060 -
Treatment of Reflux With Sleeve Gastrectomy
|
N/A | |
| Not yet recruiting |
NCT06062225 -
Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy
|
N/A | |
| Completed |
NCT01964131 -
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT06056973 -
Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis
|
Phase 4 | |
| Completed |
NCT01008696 -
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis
|
Phase 4 | |
| Recruiting |
NCT05899491 -
Role of ARMA in Selective Subset of Refractory GERD Patients.
|
N/A | |
| Recruiting |
NCT01311908 -
Incidence of Reflux Esophagitis After Pancreaticoduodenectomy
|
N/A | |
| Completed |
NCT03214081 -
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
|
||
| Not yet recruiting |
NCT01560598 -
Adipokines and the Risk of Reflux Esophagitis
|
N/A | |
| Completed |
NCT00859287 -
Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis
|
N/A | |
| Completed |
NCT00206180 -
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
|
Phase 4 | |
| Recruiting |
NCT04657848 -
Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy
|
N/A | |
| Completed |
NCT02477475 -
Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes
|
N/A | |
| Completed |
NCT03553563 -
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer
|
Phase 3 | |
| Completed |
NCT01381991 -
The Efficacy of i-Scan for Detecting Reflux Esophagitis
|
N/A | |
| Completed |
NCT04673643 -
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Reflux Esophagitis
|
N/A | |
| Recruiting |
NCT04531475 -
Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis
|
Phase 2 | |
| Completed |
NCT00634114 -
Reflux Esophagitis Phase III Study (Maintenance Treatment)
|
Phase 3 | |
| Completed |
NCT00586963 -
Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
|
N/A | |
| Completed |
NCT03388047 -
Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus
|
N/A |